Sign up for the QMED & MD+DI Daily newsletter.
Conflicting Messages on Drug-Eluting Stents
A Swedish study, based on a patient registry, found that clotting issues related to drug-eluting stents are not as frequent as previously thought. A respite for Boston Scientific and Johnson & Johnson, right? Not so fast.
September 5, 2007
1 Min Read
Yesterday another registry-based study was made public which found that drug-eluting stents are linked to higher death rates for patients who have suffered a certain kind of heart attack, reports Bloomberg News.While better than consistently bad results, conflicting results don't help a device's prospects, as doctors and patients may turn cautious about its use, whether because of conservatism or confusion. J&J issued a statement saying the new study's results should not be heeded because they are out of line with other study results. But that message may not get through, given the noise that's been introduced into the debate.
You May Also Like
Masimo Takes Apple's Hail Mary Pass in StrideFeb 29, 2024|3 Min Read
Top 40 Medical Device CompaniesFeb 29, 2024|2 Min Read
2024 Planning Guide for Medical Manufacturing AutomationFeb 29, 2024|1 Min Read
Adverse Events Reported for Hologic BioZorb Marker, BioZorb LP MarkerFeb 28, 2024|2 Min Read